Daiichi Sankyo’s Japan Research Foundation for Clinical Pharmacology 12th Annual Clinical Pharmacology Research Award

Tokyo, Japan (June 20, 2019) – Daiichi Sankyo Company, Limited today announced that its affiliate, the Japan Research Foundation for Clinical Pharmacology* (headquarters, Tokyo; Director General, Kazunori Hirokawa), has awarded its 12th “Japan Research Foundation for Clinical Pharmacology Research Award” to five young researchers.


Award recipients are selected from research papers submitted from projects funded with subsidies from the foundation, and innovative research projects with expectations for future development are eligible for the award.


The Foundation hopes that this award will motivate young clinical pharmacology researchers who are involved in the establishment of appropriate drug treatments and encourage future research results. The awards ceremony and presentation of research themes will be held on November 19, 2019.


*The mission of the Foundation is to promote clinical pharmacology and foster the development of clinical pharmacologists. The Foundation was established in 1975 and has worked on a variety of projects relating to clinical pharmacology, including promotion of research and overseas studies for Japanese researchers.

Recipients of the 12th Japan Research Foundation for Clinical Pharmacology Research Award

 

Recipient

Organization

Research theme

Okamoto-Uchida Yoshimi

Division of Medicinal Safety Science, National Institute of Health Sciences

Construction of prediction method for Stevens-Johnson syndrome/toxic epidermal necrolysis

Kato Motohiro

Division of Transplantation and Cell Therapy, Children’s Cancer Center, National Center for Child Health and Developement

Genetic polymorphism analysis to optimization of maintenance therapy for pediatric acute lymphoblastic leukemia

Sato Hiromi

Lab. of Clinical Pharmacology and Pharmacometrics, Graduate School of Pharmaceutical Sciences, Chiba University

Establishment of comprehensive analysis method for predicting drug-drug interaction involving multiple CYP molecules

Tanaka Masashi

Department of Endocrinology, Metabolism, and Hypertension Research, Clinical Research Institute, National Hospital Organization Kyoto Medical Center

Development of predictive markers and effective treatments for obesity/diabetes-related cognitive impairment

Nishida Motohiro

Division of Cardiocirculatory Signaling, National Institute for Physiological Sciences, National Institutes of Natural Sciences

Maintenance of mitochondrial quality control by cilnidipine and its repurposing to intractable diseases